Table 4.
Effects of JAK2- and STAT5 inhibitors on proliferation of canine neoplastic mast cells
IC50 values1 (μM) obtained with |
||||||
---|---|---|---|---|---|---|
Cells | R763 | TG101348 | AZD1480 | Ruxolitinib | Pimozide | Piceatannol |
C2 | 0.005-0.01 | 0.25-0.75 | 1-2 | 10-20 | 0.5-1 | 17.5-25 |
NI-1 | 0.005-0.01 | 0.1-0.5 | 1-2 | 10-20 | 1-2.5 | 10-15 |
MCT #1 | 0.01-0.05 | 1-2 | 0.1-0.5 | >20 | 0.5-1 | 25-50 |
MCT #2 | 0.005-0.01 | 1-2 | 1-2 | >20 | 2.5-5 | 25-50 |
MCT #3 | 0.01-0.05 | 0.5-1 | 0.1-0.5 | 10-20 | 0.5-1 | 25-50 |
Abbreviations: IC, inhibitory concentration; MCT, mast cell tumor.
Assessed by 3H-thymidine uptake.